Alecensa

(alectinib)
Alecensa 150 MG Oral Capsule
NO BLACK BOX WARNING

Dosage & administration

600 mg orally twice daily. Administer ALECENSA with food.

biomarker testing

Alecensa clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.
TKI (tyrosine kinase inhibitors)ALK (anaplastic lymphoma kinase)FISH break-apart probe methodology, IHC, NGS, targeted real-time PCR
TKI (tyrosine kinase inhibitors)ROS1 (ROS proto-oncogene 1)FISH break-apart probe methodology, IHC, NGS, targeted real-time PCR
TKI (tyrosine kinase inhibitors)EGFR (Epidermal Growth Factor Receptor)Real-time PCR, Sanger sequencing, NGS

drug label

Alecensa prescribing information

prior authorization

Alecensa prior authorization resources

OTHER
Complete Letter of Medical Necessity

OTHER
Coverage Authorization Appeals

PDF
Billing and Coding Guide
Learn More

Benefits investigation

Prescriber Service Form - Online Portal
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

pharmacy

Alecensa preferred pharmacy

OTHER
Pharmacy List

financial assistance

Alecensa financial assistance options

Co-pay savings program

commercial only
Prescriber Service Form - Online Portal
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only
Prescriber Service Form - Online Portal

OTHER
Alecensa Sure Start Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Prescriber Service Form - Online Portal

PDF
Genentech Patient Foundation Application Form - Prescriber Form
Learn More

patient education

Alecensa patient education

Getting started on Alecensa

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

BRAND PAGE
About Alecensa
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
Side Effects
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
View How to Take Alecensa
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Doctor Discussion Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

VIDEO
Patient Stories
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
Real Talk about ALK+ mNSCLC
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Education Brochure - English
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Education Brochure - Spanish
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
Patient Education Brochure - Chinese
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Learn More

people also ask

Alecensa FAQs

Can ALECENSA be used during pregnancy?No, ALECENSA can cause fetal harm when administered to a pregnant woman. It is advised to avoid using ALECENSA during pregnancy and advise pregnant women of the potential risk to a fetus.
Can ALECENSA be used during lactation?No, there are no data on the presence of alectinib or its metabolites in human milk, the effects of alectinib on the breastfed infant, or its effects on milk production. It is advised to not breastfeed during treatment with ALECENSA and for 1 week after the final dose.
Should females and males of reproductive potential use contraception during treatment with ALECENSA?Yes, females of reproductive potential should use effective contraception during treatment with ALECENSA and for 1 week after the final dose. Males with female partners of reproductive potential should also use effective contraception during treatment with ALECENSA and for 3 months following the final dose.
Is ALECENSA safe for pediatric use?The safety and effectiveness of ALECENSA in pediatric patients have not been established.
Is ALECENSA safe for geriatric use?Clinical studies of ALECENSA did not include a sufficient number of subjects aged 65 and older to determine whether they respond differently from younger subjects.
Is ALECENSA safe for use in patients with renal or hepatic impairment?No dose adjustment is recommended for patients with mild or moderate renal impairment or mild (Child-Pugh A) or moderate (Child-Pugh B) hepatic impairment. However, the safety of ALECENSA in patients with severe renal impairment (creatinine clearance less than 30 mL/min) or end-stage renal disease and severe hepatic impairment (Child-Pugh C) is unknown.
FAQ Data Source